General “News” category

2018 Lung Cancer Support Group Facilitator Award

2018-11-05T20:09:24+00:00November 5th, 2018|Hot Topics, News|

Monday, November 5, 2018 -- Today, Lung Cancer Alliance presented the 2018 Lung Cancer Support Group Facilitator Award to Catherine Paykin, LCSW-R, who runs a support group at New York University Perlmutter Cancer Center. The Lung Cancer Support Group Facilitator Award recognizes the uncommon dedication of a support group facilitator. Members from Catherine's support group nominated her for the award. Miranda Goff, Lung Cancer Alliance, was in New York City to present the award to Catherine. We are incredibly grateful for all [...]

FDA Approves New Treatment for ALK+ NSCLC Patients

2018-11-05T14:35:44+00:00November 2nd, 2018|Hot Topics, News|

Friday, November 2, 2018 – Today the Food and Drug Administration (FDA) granted accelerated approval to lorlatinib (LORBRENA) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.Click here to learn more. 

LCA Named 2018 Top Rated Nonprofit

2018-11-02T19:21:49+00:00November 2nd, 2018|Hot Topics, News|

Friday, November 2, 2018 - Today Lung Cancer Alliance was named a “2018 Top-Rated Nonprofit” by GreatNonprofits, the leading provider of user reviews of charities and nonprofits. The Top-Rated Nonprofit Award is based on the rating and number of reviews that Lung Cancer Alliance received from volunteers, donors and aid recipients. These are the only awards for nonprofits determined by those who have direct experience with the charities – as donors, volunteers and recipients of aid. “Lung Cancer Alliance is a great [...]

LCA Partners with UAB Comprehensive Cancer Center to Help At-Risk, Underserved Communities

2018-11-01T20:48:35+00:00November 1st, 2018|Hot Topics, News|

Washington, D.C. - November 1, 2018 –Lung Cancer Alliance (LCA) today announced a $1.6M grant from the Bristol-Myers Squibb Foundation to partner with the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center to establish the Alabama Lung Cancer Awareness, Screening and Education (ALCASE) program. The three-year effort will focus on decreasing lung cancer disparities in underserved, primarily African-American counties in Alabama through community-based education and awareness initiatives. At the same time, the program will increase capacity and access to [...]

LCA Launches Nationwide Screening Awareness Campaign

2018-10-31T20:07:28+00:00October 31st, 2018|Hot Topics, News|

 “What About Your Lungs?” Campaign Urges Individuals At-Risk for Lung Cancer to Talk to Their Doctor About Life-Saving Screening Washington, DC [Wednesday, October 31, 2018]—Responding to the need to increase national awareness about lung cancer screening and encourage those at risk to talk with their doctor, Lung Cancer Alliance (LCA) is announcing today the launch of a new campaign, “What About Your Lungs?,” to help drive this important public health initiative. “What About Your Lungs?” aims to ignite a national [...]

FDA Approves New Combination Treatment for NSCLC

2018-11-01T20:42:17+00:00October 31st, 2018|Hot Topics, News|

Tuesday, October 30, 2018 – Today the Food and Drug Administration (FDA) approved immunotherapy drug, pembrolizumab, also known as KEYTRUDA, in combination with chemotherapies, carboplatin, and either paclitaxel or nab-paclitaxel as a first-line treatment for patients with metastatic squamous non-small cell lung cancer (NSCLC). The results of the randomized trial showed an increase in overall survival, progression-free survival and overall response rate. Click here to read the full press release.

LCA Urges CMS to Remove Barriers to Screening

2018-10-25T22:07:31+00:00October 25th, 2018|Hot Topics, News|

In a number of communications to the Centers for Medicare and Medicaid Services (CMS), Lung Cancer Alliance urged the national CMS office to 1) instruct all local Medicare contractors that lung cancer screening coverage is available in all settings including Independent Diagnostic Testing Facilities across the country and 2) provide oversight to these contractors that are erroneously denying lung cancer screening.  Low dose CT scans are a nationally covered preventive screening service available to Medicare beneficiaries in all settings. Lung [...]

New First-Line Treatment Approved for NSCLC with an EGFR Mutation

2018-09-28T14:51:23+00:00September 28th, 2018|Hot Topics, News|

Friday, September 28, 2018 – Today the Food and Drug Administration approved VIZIMPRO tablets (dacomitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with an EGFR (epidermal growth factor receptor) mutation. Approval was based on a randomized trial that showed a significant improvement in progression-free survival for patients who received VIZIMPRO compared to the standard-of-care treatment. VIZIMPRO, an EGFR inhibitor targeted therapy, is an oral drug that is taken once a day. The following treatments [...]

Highlights from World Conference on Lung Cancer

2018-10-01T13:48:43+00:00September 27th, 2018|Events, Hot Topics, News|

This week, the LCA team attended the 19th Annual World Conference on Lung Cancer (September 23-26, 2018) in Toronto, Canada. Jennifer C. King, PhD, Director of Science and Research, gives us the scoop on some of the research and treatment breakthroughs, and how they impact you! https://youtu.be/Q2S7akrHUVQ SCREENING REDUCES MORTALITY! Results from the Dutch-Belgium Lung Cancer Screening trial (NELSON) showed that lung cancer screening significantly reduces lung cancer mortality. In this trial, which was more favorable than the National Lung [...]

Passage of Historic Appropriations Bill Cements Funding for Lung Cancer Research

2018-09-27T00:11:01+00:00September 27th, 2018|Hot Topics, News|

Cancer and Health Programs See Gains in FY19 Budget Wednesday, September 26, 2018 – Today, Lung Cancer Alliance (LCA) acknowledges the historic passage of the combined Department of Defense (DOD) and Labor, Health and Human Services (LHHS) appropriations package by the House following approval by the Senate. The bill will now go to the President for his signature. This package, which combines funding for DOD and LHHS along with a continuing resolution to cover other government spending from October 1 [...]

No announcement available or all announcement expired.